Safety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine: Results From a Dose-finding Clinical Trial in Healthy...

by Pornthep Chanthavanich, Edwin Anderson, Phirangkul Kerdpanich, Michael Bulitta, Niranjan Kanesa-Thasan, Matthew Hohenboken
Published 2020